Features of right lobe liver transplantation from living related donor

Authors

  • O. H. Kotenko O. O. Shalimov National Institute of Surgery and Transplantology, Kyiv, Ukraine.,
  • A. A. Minich O. O. Shalimov National Institute of Surgery and Transplantology, Kyiv, Ukraine,

DOI:

https://doi.org/10.14739/2310-1210.2019.6.186495

Keywords:

living related donor liver transplantation, intraoperative complications, outcomes in right lobe liver transplantation, morbidity

Abstract

 

Aim. To determine the peculiarities of liver transplantation using right lobe graft from living related donor with and without the middle hepatic vein inclusion.

Materials and methods. The study has analyzed preoperative, intraoperative and postoperative data of 76 recipients who underwent right lobe living donor liver transplantation with different types of hepatic vein reconstruction: group 1 – patients who received a right lobe liver graft with a middle hepatic vein, and group 2 – recipients of right lobe liver graft without the middle hepatic vein. For comparative analysis, we used biochemical and regional hemodynamic parameters in both groups during the first week and on days 10, 14, 21 and 30 after transplantation.

Results. In group 1, the higher values of Qpv – 649 ± 220 ml/min, 1222 ± 491 ml/min; 1264 ± 372 ml/min; 1166 ± 284 ml/min; 1016 ± 211 ml/min; 1095 ± 301 ml/min were observed compared to group 2 – 643 ± 230 ml/min; 1127 ± 385 ml/min; 1132 ± 372 ml/min; 1030 ± 263 ml/min; 980 ± 254 ml/min; 922 ± 293 ml/min on days 0, 1, 3, 5, 7 and 30 after transplantation, respectively, (P < 0.05). Peak systolic velocity (PSV) and resistance index of hepatic artery (RIha) were increased to higher values in group 2 (from 0.54 m/s to 0.69 m/s and from 0.63 to 0.69, respectively, P < 0.05) compared to group 1 (from 0.58 m/s up to0.62 m / s and from 0.62 to 0.69, respectively, P < 0.05). In the postoperative period, the level of total bilirubin in group 1 (grafts with middle hepatic vein) was significantly lower and the level of transaminases was higher than in group2. In the group of recipients, who had a graft with middle hepatic vein, the frequency of small-for-size syndrome (SFSS) was lower compared with group 2 (17.94 % vs 27.00 %, P < 0.05).

Conclusions. When performing the right lobe liver transplantation, the middle hepatic vein presence in the graft is correlated with a decrease in the frequency of postoperative complications and small for size syndrome development. Adequate venous outflow with sufficient volume of right lobe liver graft determines the functional graft mass.

 

References

Destounis, A., Tountas, C., Theodosis-Georgilas, A., Zahos, P., Kasinos, N., Palios, J., & Beldekos, D. (2019). An unusual case of double-chambered left ventricle. Journal Of Echocardiography, 17(3), 167-168. doi: 10.1007/s12574-018-0393-5

Au, K., Chan, S., Chok, K., Chan, A., Wong, T., Sharr, W., & Lo, C. (2015). Durability of small-for-size living donor allografts. Liver Transplantation, 21(11), 1374-1382. doi: 10.1002/lt.24205

Bhangui, P., Sah, J., Choudhary, N., Gautam, D., Gupta, V., & S, T. et al. (2019). Safe use of right lobe live donor livers with up to 20% macrovesicular steatosis without compromising donor safety and recipient outcome. Transplantation. doi: 10.1097/tp.0000000000002847

Brige, P., Hery, G., Chopinet, S., Palen, A., Azoulay, D., & Gregoire, E. (2018). Morbidity and mortality of hepatic right lobe living donors: systematic review and perspectives. Journal Of Gastrointestinal And Liver Diseases. 27(2), 169-178. doi: 10.15403/jgld.2014.1121.272.mor

Cannistrà, M., Ruggiero, M., Zullo, A., Gallelli, G., Serafini, S., & Maria, M. et al. (2016). Hepatic ischemia reperfusion injury: A systematic review of literature and the role of current drugs and biomarkers. International Journal Of Surgery, 33, suppl. 1, S57-S70. doi: 10.1016/j.ijsu.2016.05.050

Chan, K., Cheng, C., Wu, T., Wu, T., Chou, H., Lee, C., & Lee, W. (2014). Clinical strategy for the reconstruction of middle hepatic vein tributaries in right liver living donor liver transplantation. World Journal Of Surgery, 38(11), 2927-2933. doi: 10.1007/s00268-014-2667-z

Guo, H., Wang, K., Chen, K., Liu, Z., Al-Ameri, A., & Shen, Y. et al. (2019). Middle hepatic vein reconstruction in adult right lobe living donor liver transplantation improves recipient survival. Hepatobiliary & Pancreatic Diseases International, 18(2), 125-131. doi: 10.1016/j.hbpd.2019.01.006

Kim, S., Park, G., Hwang, S., Ahn, C., Kim, K., & Moon, D. et al. (2018). Results of adult living donor liver transplantation with sixth-decade donors: a propensity score matching study in a high-volume institution. Annals Of Transplantation, 23, 802-807. doi: 10.12659/aot.911550

Macshut, M., Kaido, T., Yao, S., Yagi, S., Ito, T., & Kamo, N. et al. (2019). Older Donor Age Is a Risk Factor for Negative Outcomes After Adult Living Donor Liver Transplantation Using Small‐for‐Size Grafts. Liver Transplantation, 25(10), 1524-1532. doi: 10.1002/lt.25601

Marubashi, S., Nagano, H., Eguchi, H., Wada, H., Asaoka, T., & Tomimaru, Y. et al. (2016). Minimum graft size calculated from preoperative recipient status in living donor liver transplantation. Liver Transplantation, 22(5), 599-606. doi: 10.1002/lt.24388

Nadalin, S., Capobianco, I., Panaro, F., Di Francesco, F., Troisi, R., & Sainz-Barriga M. et al. (2016). Living donor liver transplantation in Europe. Hepatobiliary Surg Nutr, 5(2),159-175. doi: 10.3978/j.issn.2304-3881.2015.10.04

Shen, Z., Gu, C., Zheng, H., Pan, C., Deng, Y., & Du, H. et al. (2019). A twenty-year review of clinical liver transplantation. Zhonghua Wei Zhong Bing Ji Jiu Yi Xue, 31(3), 269-280. doi: 10.3760/cma.j.issn.2095-4352.2019.03.004 [in Chinese].

Shoreem, H., Gad, E., Soliman, H., Hegazy, O., Saleh, S., & Zakaria, H. et al. (2017). Small for size syndrome difficult dilemma: Lessons from 10 years single centre experience in living donor liver transplantation. World Journal Of Hepatology, 9(21), 930. doi: 10.4254/wjh.v9.i21.930

Siniscalchi, A., Gamberini, L., Laici, C., Bardi, T., Ercolani, G., Lorenzini, L., & Faenza, S. (2016). Post reperfusion syndrome during liver transplantation: From pathophysiology to therapy and preventive strategies. World journal of gastroenterology, 22(4), 1551-1569. doi: 10.3748/wjg.v22.i4.1551

Uchiyama, H., Shirabe, K., Kimura, K., Yoshizumi, T., Ikegami, T., Harimoto, N., & Maehara, Y. (2016). Outcomes of adult-to-adult living donor liver transplantation in 321 recipients. Liver Transplantation, 22(3), 305-315. doi: 10.1002/lt.24378

Umgelter, A., Hapfelmeier, A., Kopp, W., van Rosmalen, M., Rogiers, X., & Guba, M. (2017). Disparities in Eurotransplant liver transplantation wait-list outcome between patients with and without model for end-stage liver disease exceptions. Liver Transplantation, 23(10), 1256-1265. doi: 10.1002/lt.24805

Yesmembetov, K., Sultanaliyev, T., Mukazhanov, A., Zhexembayev, A., Kuttymuratov, G., & Spatayev, Z. et al. (2018). Prognosis of patients following liver transplant from deceased and living donors. Experimental And Clinical Transplantation, 16(1), suppl. 1, 152-153. doi: 10.6002/ect.TOND-TDTD2017.P42

Yi, P., Zhang, M., & Xu, M. (2015). Management of the middle hepatic vein in right lobe living donor liver transplantation: A meta-analysis. Journal Of Huazhong University Of Science And Technology [Medical Sciences], 35(4), 600-605. doi: 10.1007/s11596-015-1477-3

How to Cite

1.
Kotenko OH, Minich AA. Features of right lobe liver transplantation from living related donor. Zaporozhye Medical Journal [Internet]. 2019Dec.11 [cited 2024Dec.23];(6). Available from: http://zmj.zsmu.edu.ua/article/view/186495

Issue

Section

Original research